Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma

Springer Science and Business Media LLC - Tập 94 - Trang 279-284 - 2011
Yasushi Terasaki1, Hiroki Yamamoto1, Hiroaki Kiyokawa1, Hirokazu Okumura2, Katsuhiko Saito3, Ryo Ichinohasama4, Youichi Ishida1
1Division of Internal Medicine, Toyama City Hospital, Toyama, Japan
2Division of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan
3Division of Pathology, Toyama City Hospital, Toyama, Japan
4Division of Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan

Tóm tắt

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma usually confined to the body cavities of predominantly immunosuppressed patients infected with human herpes virus-8 (HHV-8). In PEL, malignant cells are usually negative for B-cell markers, such as CD19, CD20, and CD79a, but are positive for activation and plasma cell-related markers, such as CD30, CD38, and CD138. It has been reported that HHV-8-unrelated PEL shows high expression of B-cell markers, which is referred to as PEL-like lymphoma. Here, we report two cases of HHV-8-unrelated HIV-negative PEL-like lymphoma in which malignant cells regressed spontaneously after effusion drainage alone. These cells expressed B-cell markers, such as CD20. No chemotherapy was given to either patient, as they were of an advanced age, and both achieved a complete response by effusion drainage alone. One showed a complete response for 16 months after effusion drainage, and the other has survived for 11 months with a complete response. This suggests that sufficient drainage of serous effusion may induce and maintain a complete response in some patients with HHV-8-unrelated HIV-negative PEL-like lymphoma, which represents an excellent treatment option for elderly patients with this disease.

Tài liệu tham khảo

Said J, Ceaarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 260–1. Kobayashi Y, Kamitsuji Y, Kuroda J, Tsunoda S, Uoshima N, Kimura S, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acuta Haematol. 2007;117:132–44. Adiguzel C, Bozkurt SU, Kaygusuz I, Uzay A, Tecimer T, Bayik M. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. APMIS. 2009;117:222–9. Carbone A, Globhini A. PEL and HHV-unrelated effusion lymphomas: classification and diagnosis. Cancer. 2008;114:225–7. Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998;22:1528–37. Saiki M, Saitoh T, Inoue M, Hatta Y, Yamazaki T, Itoh T, et al. Human herpesvirus-8 negative primary effusion lymphoma with complete clinical remission after removal of ascites. Rinsho Ketsueki. 2002;43:548–53. Japanese. Inoue S, Miyamoto T, Yoshino T, Yamadori I, Hagari Y, Yamamoto O. Primary effusion lymphoma with skin involvement. J Clin Pathol. 2006;59:1221–2. Terasaki Y, Okumura H, Saito K, Sato Y, Yoshino T, Ichinohasama R, Ishida Y. HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med. 2008;47:2175–8. Suzuki K, Ino K, Sugawara Y, Mizutani M, Sekine T, Katayama N. Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab. Gan To Kagaku Ryoho. 2008;35:691–4. Japanese. De Filippi R, Iaccarino G, Frigeri F, Di Francia R, Crisci S, Capobianco G, et al. Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma. Br J Haematol. 2009;147:405–8. Tsagarakis NJ, Argyrou A, Gortzolidis G, Kentrou N, Papadhimitriou SI, Tzanetou K, et al. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia. Int J Hematol. 2009;90:94–8. Taira T, Nagasaki A, Okudaira T, Miyagi T, Iha K, Takushi Y, et al. HIV- and HHV-8-negative primary effusion lymphoma-like lymphoma presenting with lymphomatous effusions complicated by cardiac tamponade-a case report. Gan To Kagaku Ryoho. 2009;36:1195–8. Japanese. Takahashi T, Hangaishi A, Yamamoto G, Ichikawa M, Imai Y, Kurokawa M. HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases. Am J Hematol. 2010;85:85–7. Kagoya Y, Takahashi T, Yoshimoto T, Ichikawa M, Hangaishi A, Fukayama M, et al. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case. Ann Hematol. 2011;90:219–20. Sandra Horning J, Saul Rosenberg A. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med. 1984;311:1471–5.